The increase would push the annual cost of fragility fractures well above the €4.3 billion recorded in 2019, when more than 285,000 new fractures occurred — roughly one every two minutes.
Specialists at the briefing warned that the disease remains widely underdiagnosed because it progresses silently until a fracture reveals it. The forecast draws on the ScoreCard for Osteoporosis in Europe (Scope 21), which projects healthcare spending on fractures to rise 27.9% over the next decade.
Grünenthal and the Asociación Nacional de Informadores de la Salud (ANIS) convened the briefing, titled Romper mitos para prevenir fracturas, to mark World Osteoporosis Day, which falls on 20 October each year.
“My life did a 180-degree turn. The fractures limited my mobility and functionality and left me with chronic pain,” said Sandra Toril, a nurse who was 39 when a hip fracture during late pregnancy led to the discovery of seven vertebral fractures and a diagnosis of severe osteoporosis. Toril told Cinco Días that clinicians initially attributed her pain to muscular issues or postpartum depression, delaying her diagnosis by months.
Dr. Alejandro Ordás, a traumatologist at Ramón y Cajal University Hospital and Ruber Internacional, said conditions such as rheumatoid arthritis, thyroid and kidney disorders, and medications including corticosteroids, benzodiazepines and anticonvulsives accelerate bone loss, according to Cinco Días. In Toril’s case, heparin used during pregnancy and undiagnosed celiac disease likely contributed.
Epidemiological data cited at the briefing show that 54.4 percent of Spaniards over 50 have osteopenia — a precursor to osteoporosis — and 10.7 percent have the disease itself, including an estimated 1.3 million women aged 65 or older.
After a first fragility fracture, the risk of a second within two years multiplies by five. Experts said the chronic, progressive condition affects nearly three million people in Spain and carries a greater societal burden than chronic obstructive pulmonary disease or stroke.
Hip and vertebral fractures carry the gravest consequences. Thirty percent of patients develop chronic pain and half never regain their previous functional capacity. One in four hip-fracture patients cannot return home and requires residential care, while 20 percent die within the first year from complications of the injury and hospitalization.
He said that access to DEXA is limited by equipment availability, cost and waiting lists, and suggested heel ultrasound densitometry as a radiation-free alternative.
“This evaluation should begin in women at menopause, around 45 to 50 years old, and in men from age 70 if they have risk factors,” Baquero said.
Lifestyle measures — adequate calcium, vitamin D and protein intake, plus regular strength and balance exercise — help preserve bone mass and reduce falls. Pharmacological treatment includes antiresorptive agents that slow bone loss and osteoanabolic drugs that stimulate formation. Ordás said monoclonal antibodies targeting new metabolic pathways are under investigation, expanding future therapeutic options.
Keep reading